Itau Unibanco Holding S.A.’s Nektar Therapeutics NKTR Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-200	Closed	-$54K	–	455
2021 Q3	$54K	Buy	200 +71	+55%	+$17.1K	﹤0.01%	257
2021 Q2	$33K	Buy	+129	New	+$35.7K	﹤0.01%	254
2019 Q4	–	Sell	-117	Closed	-$62K	–	950
2019 Q3	$62K	Hold	117	–	–	﹤0.01%	228
2019 Q2	$62K	Sell	117 -93	-44%	-$46.6K	﹤0.01%	546
2019 Q1	$102K	Hold	210	–	–	﹤0.01%	373
2018 Q4	$102K	Buy	210 +35	+20%	+$21.1K	﹤0.01%	373
2018 Q3	$160K	Buy	+175	New	+$149K	0.01%	343
2018 Q2	–	Sell	-11	Closed	-$17K	–	803
2018 Q1	$17K	Buy	+11	New	+$14.2K	﹤0.01%	542

Other funds holding NKTR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Itau Unibanco Holding S.A.'s NKTR Position: Q4 2021 in Review

Itau Unibanco Holding S.A. sold out of Nektar Therapeutics (NKTR) in Q4 2021, closing a stake of 200 shares — an estimated $54K sold.

Itau Unibanco Holding S.A. first reported a position in NKTR in Q1 2018 and held it in 8 quarters. The position peaked at $160K in Q3 2018. 240 funds tracked by Wall St. Rank hold NKTR as of Q4 2021.

Itau Unibanco Holding S.A. reported no remaining Nektar Therapeutics position as of Q4 2021 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 200 Nektar Therapeutics shares in Q4 2021, an estimated $54K.
Itau Unibanco Holding S.A. first reported a position in Nektar Therapeutics in Q1 2018 and held it in 8 quarters.
Itau Unibanco Holding S.A.'s Nektar Therapeutics position peaked at $160K in Q3 2018.
240 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2021.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2021, filed 14 Feb 2022.